However, although this may appear, in part, to have driven the difference between the T1DM and control cohorts, this could not be the case as ACE inhibitor use was similar in the two T1DM cohorts, while SAA levels were different. The gene discussed is SAA1; the disease is type 1 diabetes mellitus.